In conclusion, we first found that DNAAF5 was highly expressed in HCC tissues through multiple groups of clinical samples and the TCGA database, and elevated DNAAF5 levels negatively correlated with prognostic outcomes for HCC patients. Here, DNAAF5 is linked to hepatocellular carcinoma.